Healthcare Triangle Faces Delisting Concerns
Ticker: HCTI · Form: 8-K · Filed: Sep 6, 2024 · CIK: 1839285
| Field | Detail |
|---|---|
| Company | Healthcare Triangle, Inc. (HCTI) |
| Form Type | 8-K |
| Filed Date | Sep 6, 2024 |
| Risk Level | high |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.00001, $2,500,000 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, compliance
Related Tickers: HTRI
TL;DR
HTRI might be delisted - stock could tank.
AI Summary
Healthcare Triangle, Inc. filed an 8-K on September 6, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with the earliest event date being September 3, 2024. The company, incorporated in Delaware, is based in Pleasanton, CA.
Why It Matters
This filing indicates potential issues with Healthcare Triangle's continued listing on an exchange, which could significantly impact its stock value and trading liquidity.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's continued operation and investor confidence.
Key Players & Entities
- Healthcare Triangle, Inc. (company) — Registrant
- September 3, 2024 (date) — Earliest event reported
- September 6, 2024 (date) — Filing date
- Pleasanton, CA (location) — Principal executive offices
FAQ
What specific listing rule or standard has Healthcare Triangle, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that was not met, only that a notice has been issued regarding a failure to satisfy a continued listing rule or standard.
What is the effective date of the potential delisting or transfer of listing?
The filing reports the earliest event date as September 3, 2024, and the date of change as September 6, 2024, but does not specify an effective date for delisting or transfer.
Has Healthcare Triangle, Inc. taken any steps to address the listing deficiency?
The provided text of the 8-K filing does not contain information about any steps taken by the company to address the listing deficiency.
What is the company's stock ticker symbol?
The filing does not explicitly state the stock ticker symbol, but the context suggests it is related to 'Healthcare Triangle, Inc.'
Where is Healthcare Triangle, Inc. incorporated?
Healthcare Triangle, Inc. is incorporated in Delaware.
Filing Stats: 955 words · 4 min read · ~3 pages · Grade level 13.9 · Accepted 2024-09-06 17:15:11
Key Financial Figures
- $0.00001 — ch registered Common Stock, par value $0.00001 per share HCTI The Nasdaq Stock Mar
- $2,500,000 — that it did not comply with the minimum $2,500,000 stockholders' equity requirement for co
Filing Documents
- ea0213835-8k_healthcare.htm (8-K) — 39KB
- 0001213900-24-076604.txt ( ) — 213KB
- hcti-20240903.xsd (EX-101.SCH) — 3KB
- hcti-20240903_lab.xml (EX-101.LAB) — 33KB
- hcti-20240903_pre.xml (EX-101.PRE) — 22KB
- ea0213835-8k_healthcare_htm.xml (XML) — 4KB
01
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, on March 20, 2024, the Listing Qualifications department of The Nasdaq Stock Market LLC (the "Staff") notified Healthcare Triangle, Inc. (the "Company") that it did not comply with the minimum $2,500,000 stockholders' equity requirement for continued listing set forth in Nasdaq Listing Rule 5550(b)(1) (the "Rule"); and post Company's submission of a plan to regain compliance on May 2, 2024, the Staff granted the Company's request for an extension until September 16, 2024 to comply with this requirement. On September 3, 2024, the Company received a delist determination letter from the Staff advising the Company that the Staff had determined that the Company did not meet the terms of the extension. Specifically, the Company did not complete its proposed transactions and was unable to evidence compliance with the Rule. As a result, unless the Company requests an appeal of the Staff's determination, trading of the Company's common stock will be suspended at the opening of business on September 12, 2024, and a Form 25-NSE will be filed with the Securities and Exchange Commission (the "SEC"), which will remove the Company's securities from listing and registration on The Nasdaq Stock Market ("Nasdaq"). The Company intends to submit a hearing request to the Nasdaq Hearings Panel (the "Panel") no later than 4:00 p.m. Eastern Time on September 10, 2024, which request will stay suspension of the Company's securities and the filing of the Form 25-NSE pending the Panel's decision. At the Panel hearing, the Company intends to present a plan to regain compliance with the minimum stockholders' equity requirement. In the interim, the Company's common stock will continue to trade on the Nasdaq Capital Market under the symbol "HCTI" pending the ultimate conclusion of the hearing process. There can be no assurance that the Company's plan wil